Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Maravai Lifesciences Holdings Inc Cl A (MRVI)

Maravai Lifesciences Holdings Inc Cl A (MRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Maravai LifeSciences Announces November 2024 Investor Conference Schedule

MRVI : 5.22 (+5.24%)
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript

MRVI earnings call for the period ending September 30, 2024.

MRVI : 5.22 (+5.24%)
Maravai LifeSciences Reports Third Quarter 2024 Financial Results

MRVI : 5.22 (+5.24%)
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024

MRVI : 5.22 (+5.24%)
Maravai LifeSciences (MRVI) Q2 2024 Earnings Call Transcript

MRVI earnings call for the period ending June 30, 2024.

MRVI : 5.22 (+5.24%)
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient...

APDN : 0.1550 (-2.08%)
MRVI : 5.22 (+5.24%)
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability -- Applied DNA Secures Commercial Linea RNAP Quantity Sufficient...

APDN : 0.1550 (-2.08%)
MRVI : 5.22 (+5.24%)
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript

MRVI earnings call for the period ending March 31, 2024.

MRVI : 5.22 (+5.24%)
Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript

MRVI earnings call for the period ending December 31, 2023.

MRVI : 5.22 (+5.24%)
Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Transcript

MRVI earnings call for the period ending September 30, 2023.

MRVI : 5.22 (+5.24%)

Barchart Exclusives

Thanksgiving, GDP and Other Key Things to Watch This Week
This week is a short week with the holiday, but there are still plenty of things to watch on the news front. In addition, there is increasing tension overseas again as the Russia/Ukraine conflict appears to be getting more intense. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar